By Drug Target Review2024-04-30T12:00:33
The new organoids demonstrate a greater diversity of TECs in culture and are capable of maturing T cells.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-25T15:00:00Z 2026-03-25T16:00:00Z
Sponsored by Yokogawa
2026-03-18T14:47:08Z
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2024-01-10T08:56:17
Sponsored by Leica Microsystems
2023-07-04T10:05:58
Sponsored by Revvity
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2023-03-28T11:38:32
Sponsored by Bio-Techne
Site powered by Webvision Cloud